Dashboard
Manage Tickers

AORT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

needham-maintains-buy-on-artivion-raises-price-target-to-58
Needham Maintains Buy on Artivion, Raises ...
11/07/2025 10:01:10

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $50 to $58.

artivion-raises-fy2025-sales-guidance-from-435000m-443000m-to-439000m-445000m-vs-437718m-est
Artivion Raises FY2025 Sales Guidance from...
11/06/2025 21:35:01

Artivion (NYSE:AORT) raises FY2025 sales outlook from $435.000 million-$443.000 million to $439.000 million-$445.000 million vs...

artivion-q3-adj-eps-016-sales-113388m-beat-110437m-estimate
Artivion Q3 Adj. EPS $0.16, Sales $113.388...
11/06/2025 21:34:14

Artivion (NYSE:AORT) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.02 by 841.1...

artivion-treats-first-patient-in-artizen-pivotal-study-evaluating-arcevo-lsa-hybrid-stent-graft-system-for-acute-chronic-arch-pathologies
Artivion Treats First Patient In ARTIZEN P...
11/06/2025 13:36:32

Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treat...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

artivion-to-present-at-39th-european-association-for-cardio-thoracic-surgery-annual-meeting
Artivion To Present At 39th European Assoc...
10/13/2025 12:05:54

jmp-securities-maintains-market-outperform-on-artivion-raises-price-target-to-47
JMP Securities Maintains Market Outperform...
10/10/2025 13:01:29

JMP Securities analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target fr...

artivion-to-acquire-1300-east-anderson-lane-property-for-1205m-and-1200-east-anderson-lane-property-for-845m
Artivion To Acquire 1300 East Anderson Lan...
09/29/2025 20:48:42

On September 26, 2025, Artivion, Inc. (the "Company") entered into two Real Estate Purchase and Sale Contracts having s...

stifel-maintains-buy-on-artivion-raises-price-target-to-46
Stifel Maintains Buy on Artivion, Raises P...
09/29/2025 14:55:30

Stifel analyst Rick Wise maintains Artivion (NYSE: AORT) with a Buy and raises the price target from $40 to $46.

beyond-the-numbers-7-analysts-discuss-artivion-stock
Beyond The Numbers: 7 Analysts Discuss Art...
09/29/2025 13:10:04

Across the recent three months, 7 analysts have shared their insights on Artivion (NYSE: AORT), expressing a variety of opinion...

canaccord-genuity-maintains-buy-on-artivion-raises-price-target-to-50
Canaccord Genuity Maintains Buy on Artivio...
09/29/2025 12:13:21

Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE: AORT) with a Buy and raises the price target from $41 t...

needham-maintains-buy-on-artivion-raises-price-target-to-50
Needham Maintains Buy on Artivion, Raises ...
08/22/2025 11:11:09

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $45 to $50.

ladenburg-thalmann-downgrades-artivion-to-neutral-raises-price-target-to-388
Ladenburg Thalmann Downgrades Artivion to ...
08/13/2025 15:16:48

Ladenburg Thalmann analyst Jeff Cohen downgrades Artivion (NYSE:AORT) from Buy to Neutral and raises the price target from $...

artivion-appoints-lance-a-berry-the-companys-current-executive-vice-president-cfo-and-treasurer-as-chief-operating-officer-effective-as-of-august-11-2025
Artivion Appoints Lance A. Berry, The Comp...
08/11/2025 17:30:11

-SEC Filing

canaccord-genuity-maintains-buy-on-artivion-raises-price-target-to-41
Canaccord Genuity Maintains Buy on Artivio...
08/08/2025 21:02:39

Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $35 to...

deep-dive-into-artivion-stock-analyst-perspectives-4-ratings
Deep Dive Into Artivion Stock: Analyst Per...
08/08/2025 21:02:05

jmp-securities-maintains-market-outperform-on-artivion-raises-price-target-to-42
JMP Securities Maintains Market Outperform...
08/08/2025 15:28:16

JMP Securities analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target fr...

stifel-maintains-buy-on-artivion-raises-price-target-to-40
Stifel Maintains Buy on Artivion, Raises P...
08/08/2025 13:42:46

Stifel analyst Rick Wise maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $36 to $40.

needham-maintains-buy-on-artivion-raises-price-target-to-45
Needham Maintains Buy on Artivion, Raises ...
08/08/2025 11:36:24

Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $32 to $45.

artivion-raises-fy2025-sales-guidance-from-42300m-43500m-to-43500m-44300m-vs-42740m-est
Artivion Raises FY2025 Sales Guidance from...
08/07/2025 20:13:35

Artivion (NYSE:AORT) raises FY2025 sales outlook from $423.00 million-$435.00 million to $435.00 million-$443.00 million vs $42...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION